Jeremy Green insider trades: Attovia Therapeutics (ATTO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeremy reports to the SEC
and 33 more companies
Open-market buys and sales
54 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | ATTO | ↑ Buy | 400,000 | $17.00 | $6.8M | Indirect | Aug 7, 2026 (1d) |
| Aug 6, 2026 | ATTO | ↑ Buy | 200,000 | $17.00 | $3.4M | Direct | Aug 7, 2026 (1d) |
| Apr 2, 2026 | ADCT | ↓ Sell | 3,000,000 | $3.34 | $10.0M | Indirect | Apr 2, 2026 (0d) |
| Apr 2, 2026 | ADCT | ↓ Sell | 2,880,415 | $3.34 | $9.6M | Direct | Apr 2, 2026 (0d) |
| Dec 20, 2024 | FATE | ↑ Buy | 397,964 | $1.68 | $669K | Indirect | Dec 26, 2024 (6d) |
| Dec 20, 2024 | FATE | ↓ Sell | 341,633 | $1.68 | $574K | Indirect | Dec 26, 2024 (6d) |
| Dec 11, 2024 | ADCT | ↑ Buy | 100,000 | $3.04 | $305K | Indirect | Dec 13, 2024 (2d) |
| Dec 11, 2024 | ADCT | ↑ Buy | 100,000 | $3.04 | $305K | Direct | Dec 13, 2024 (2d) |
| Dec 4, 2024 | STTK | ↓ Sell | 133,371 | $1.25 | $167K | Indirect | Dec 6, 2024 (2d) |
| Dec 4, 2024 | STTK | ↑ Buy | 133,371 | $1.25 | $167K | Indirect | Dec 6, 2024 (2d) |
| Dec 4, 2024 | ADCT | ↓ Sell | 25,352 | $2.07 | $52K | Indirect | Dec 6, 2024 (2d) |
| Jul 1, 2024 | ADCT | ↑ Buy | 400,000 | $2.81 | $1.1M | Indirect | Jul 3, 2024 (2d) |
| Jul 1, 2024 | ADCT | ↑ Buy | 400,000 | $2.81 | $1.1M | Direct | Jul 3, 2024 (2d) |
| Mar 1, 2024 | ABSI | ↑ Buy | 222,222 | $4.50 | $1000K | Indirect | Mar 5, 2024 (4d) |
| Dec 26, 2023 | FATE | ↑ Buy | 44,630 | $3.72 | $166K | Indirect | Dec 28, 2023 (2d) |
| Nov 20, 2023 | AUGX | ↑ Buy | 750,000 | $4.00 | $3.0M | Direct | Nov 22, 2023 (2d) |
| Nov 20, 2023 | AUGX | ↑ Buy | 750,000 | $4.00 | $3.0M | Indirect | Nov 22, 2023 (2d) |
| Jun 29, 2023 | IGMS | ↓ Sell | 80,423 | $9.42 | $758K | Indirect | Jul 3, 2023 (4d) |
| Jun 29, 2023 | IGMS | ↑ Buy | 80,423 | $9.42 | $758K | Indirect | Jul 3, 2023 (4d) |
| Apr 21, 2023 | FATE | ↑ Buy | 276,639 | $6.17 | $1.7M | Indirect | Apr 21, 2023 (0d) |
| Apr 14, 2023 | FATE | ↓ Sell | 302,339 | $5.84 | $1.8M | Indirect | Apr 17, 2023 (3d) |
| Apr 14, 2023 | FATE | ↑ Buy | 25,700 | $6.00 | $154K | Indirect | Apr 17, 2023 (3d) |
| Nov 2, 2021 | TRDA | ↑ Buy | 1,000,000 | $20.00 | $20.0M | Indirect | Nov 4, 2021 (2d) |
| Oct 28, 2021 | AUGX | ↑ Buy | 1,625,000 | $4.00 | $6.5M | Indirect | Nov 1, 2021 (4d) |
| Aug 10, 2021 | ADGI | ↑ Buy | 1,470,000 | $17.00 | $25.0M | Indirect | Aug 12, 2021 (2d) |
| Jul 26, 2021 | ABSI | ↑ Buy | 1,875,000 | $16.00 | $30.0M | Indirect | Jul 28, 2021 (2d) |
| Jun 21, 2021 | VERV | ↑ Buy | 1,050,000 | $19.00 | $19.9M | Indirect | Jun 23, 2021 (2d) |
| Jan 8, 2021 | FATE | ↑ Buy | 327,485 | $85.50 | $28.0M | Indirect | Jan 12, 2021 (4d) |
| Dec 28, 2020 | APRE | ↓ Sell | 500,000 | $5.58 | $2.8M | Indirect | Feb 16, 2021 (50d) |
| Oct 14, 2020 | STTK | ↑ Buy | 3,441,176 | $17.34 | $59.7M | Indirect | Oct 15, 2020 (1d) |
| Oct 5, 2020 | AUGX | ↑ Buy | 5,000,000 | $3.00 | $15.0M | Indirect | Oct 7, 2020 (2d) |
| Sep 9, 2020 | IGMS | ↑ Buy | 144,806 | $50.52 | $7.3M | Indirect | Sep 9, 2020 (0d) |
| Sep 3, 2020 | IGMS | ↑ Buy | 136,649 | $47.21 | $6.5M | Indirect | Sep 3, 2020 (0d) |
| Jun 11, 2020 | FATE | ↑ Buy | 1,412,928 | $28.31 | $40.0M | Indirect | Jun 17, 2020 (6d) |
| Apr 2, 2020 | NLTX | ↑ Buy | 194,300 | $10.35 | $2.0M | Indirect | Apr 6, 2020 (4d) |
| Apr 2, 2020 | NLTX | ↓ Sell | 19,668 | $11.19 | $220K | Indirect | Apr 6, 2020 (4d) |
| Oct 7, 2019 | APRE | ↑ Buy | 400,000 | $15.00 | $6.0M | Indirect | Oct 8, 2019 (1d) |
| Sep 16, 2019 | FATE | ↑ Buy | 857,143 | $17.50 | $15.0M | Indirect | Sep 17, 2019 (1d) |
| Feb 19, 2019 | XERS | ↑ Buy | 588,000 | $10.00 | $5.9M | See note | Feb 21, 2019 (2d) |
| Sep 25, 2018 | FATE | ↑ Buy | 3,703,704 | $13.50 | $50.0M | Indirect | Sep 27, 2018 (2d) |
| Jun 25, 2018 | XERS | ↑ Buy | 666,668 | $15.00 | $10.0M | Indirect | Jun 27, 2018 (2d) |
| Sep 28, 2016 | ARRY | ↓ Sell | 2,492,578 | $6.36 | $15.9M | Indirect | Sep 30, 2016 (2d) |
| Sep 15, 2016 | ARRY | ↑ Buy | 400,000 | $3.51 | $1.4M | Indirect | Sep 16, 2016 (1d) |
| Sep 15, 2016 | ARRY | ↓ Sell | 400,000 | $3.50 | $1.4M | Indirect | Sep 16, 2016 (1d) |
| Jul 6, 2016 | SYRS | ↑ Buy | 432,746 | $12.50 | $5.4M | Direct | Jul 7, 2016 (1d) |
| Jun 3, 2016 | FOLD | ↑ Buy | 66,300 | $7.20 | $477K | Indirect | Jun 13, 2016 (10d) |
| Jan 20, 2016 | ARRY | ↑ Buy | 300,000 | $3.19 | $957K | Indirect | Jan 22, 2016 (2d) |
| Jan 12, 2016 | ARRY | ↑ Buy | 75,000 | $3.60 | $270K | Indirect | Jan 14, 2016 (2d) |
| Jan 11, 2016 | ARRY | ↑ Buy | 925,000 | $3.67 | $3.4M | Indirect | Jan 11, 2016 (0d) |
| Oct 1, 2015 | ARRY | ↑ Buy | 782,592 | $4.58 | $3.6M | Indirect | Oct 1, 2015 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ATTO insiders
Open-market trades in the last 12 months
About Jeremy Green's insider trades
Jeremy Green is a 10% owner of Attovia Therapeutics (ATTO). Since Aug 10, 2015, Jeremy has reported 43 open-market purchases worth $399.7M and 11 sales worth $43.2M on SEC Form 4. In the last 12 months: 2 buys ($10.2M) and 2 sales ($19.6M).
Their filings also include grants and awards (71 filings), conversions (31 filings), other transactions (24 filings), shares returned to the company (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATTO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.